Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis
In myasthenia gravis (MG) patients on intravenous methylprednisolone (IVMP) therapy, initial deterioration should be carefully monitored because it may cause myasthenic crisis. The aim of this study was to investigate the onset, duration and related factors of initial deterioration from the first IVMP in MG patients.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Takamichi Sugimoto, Kazuhide Ochi, Ruoyi Ishikawa, Taku Tazuma, Masahiro Hayashi, Naoko Mine, Hiroyuki Naito, Eiichi Nomura, Tatsuo Kohriyama, Takemori Yamawaki Source Type: research